JP2002508338A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002508338A5 JP2002508338A5 JP2000538720A JP2000538720A JP2002508338A5 JP 2002508338 A5 JP2002508338 A5 JP 2002508338A5 JP 2000538720 A JP2000538720 A JP 2000538720A JP 2000538720 A JP2000538720 A JP 2000538720A JP 2002508338 A5 JP2002508338 A5 JP 2002508338A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- hiv
- composition according
- lentivirus
- vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 description 4
- 241000725303 Human immunodeficiency virus Species 0.000 description 3
- 241000713666 Lentivirus Species 0.000 description 2
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6957997P | 1997-12-12 | 1997-12-12 | |
US60/069,579 | 1997-12-12 | ||
PCT/US1998/025720 WO1999030742A1 (en) | 1997-12-12 | 1998-12-11 | Therapeutic use of lentiviral vectors |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2002508338A JP2002508338A (ja) | 2002-03-19 |
JP2002508338A5 true JP2002508338A5 (ru) | 2006-01-26 |
Family
ID=22089926
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000538720A Pending JP2002508338A (ja) | 1997-12-12 | 1998-12-11 | レンチウィルスベクターの治療使用 |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1037669A4 (ru) |
JP (1) | JP2002508338A (ru) |
KR (1) | KR20010033062A (ru) |
AU (1) | AU749059B2 (ru) |
CA (1) | CA2314683A1 (ru) |
WO (1) | WO1999030742A1 (ru) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001030847A1 (en) | 1999-10-22 | 2001-05-03 | Aventis Pasteur Limited | Modified gp100 and uses thereof |
US6656706B2 (en) | 1999-12-23 | 2003-12-02 | The United States Of America As Represented By The Department Of Health And Human Services | Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes |
ES2276788T3 (es) | 2000-05-10 | 2007-07-01 | Sanofi Pasteur Limited | Polipeptidos inmunogenos codificados por minigenes mage y sus utilizaciones. |
US6712612B1 (en) | 2000-12-12 | 2004-03-30 | Genecure Llc | Safe and stable retroviral helper cell line and related compositions and methods |
JP2006516548A (ja) | 2002-12-30 | 2006-07-06 | アンジオテック インターナショナル アクツィエン ゲゼルシャフト | 迅速ゲル化ポリマー組成物からの薬物送達法 |
EP1616012B1 (en) | 2003-04-24 | 2007-12-19 | Fondazione Centro San Raffaele Del Monte Tabor | Synthetic bi-directional promoters and uses thereof |
JP2011500036A (ja) | 2007-10-15 | 2011-01-06 | ザ ユニバーシティー オブ クイーンズランド | 構築物系およびその使用 |
US9795658B2 (en) | 2010-04-20 | 2017-10-24 | Admedus Vaccines Pty Ltd | Expression system for modulating an immune response |
CN108601951B (zh) | 2015-12-09 | 2022-11-22 | 金港医疗(澳大利亚)私人有限公司 | 用于治疗的免疫调节组合物 |
WO2018018082A1 (en) | 2016-07-26 | 2018-02-01 | The Australian National University | Immunostimulatory compositions and uses therefor |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996028565A1 (fr) * | 1995-03-16 | 1996-09-19 | Hisamitsu Pharmaceutical Co., Inc. | Nouveau recombinant genique |
US5650309A (en) * | 1995-05-16 | 1997-07-22 | The Regents Of The University Of California | Viral vectors |
US6013516A (en) * | 1995-10-06 | 2000-01-11 | The Salk Institute For Biological Studies | Vector and method of use for nucleic acid delivery to non-dividing cells |
WO1997020052A1 (en) * | 1995-11-28 | 1997-06-05 | Clinical Technologies, Inc. | Recombinant hiv and modified packaging cells and method for treating acquired immune deficiency syndrome |
PT871757E (pt) * | 1995-11-28 | 2003-08-29 | Univ Johns Hopkins Med | Vectores virais condicionalmente replicantes e sua utilizacao |
ATE429505T1 (de) * | 1996-02-21 | 2009-05-15 | Genetic Immunity Kft | Verfahren und zusammensetzungen zur genetisch schützenden und therapeutischen immunisierung |
US6004799A (en) * | 1996-03-05 | 1999-12-21 | The Regents Of The University Of California | Recombinant live feline immunodeficiency virus and proviral DNA vaccines |
WO1998003669A2 (en) * | 1996-07-22 | 1998-01-29 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Vectors for inhibiting hiv and tumor growth |
EP0991771A2 (en) * | 1997-03-06 | 2000-04-12 | Klaus Überla | Lentivirus based vector and vector system |
GB9704977D0 (en) * | 1997-03-11 | 1997-04-30 | Univ Glasgow | FIV vaccine |
WO1999004026A2 (en) * | 1997-07-18 | 1999-01-28 | Chiron Corporation | Lentiviral vectors |
-
1998
- 1998-12-11 CA CA002314683A patent/CA2314683A1/en not_active Abandoned
- 1998-12-11 AU AU18035/99A patent/AU749059B2/en not_active Ceased
- 1998-12-11 WO PCT/US1998/025720 patent/WO1999030742A1/en not_active Application Discontinuation
- 1998-12-11 JP JP2000538720A patent/JP2002508338A/ja active Pending
- 1998-12-11 KR KR1020007006423A patent/KR20010033062A/ko not_active Application Discontinuation
- 1998-12-11 EP EP98962895A patent/EP1037669A4/en not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1068918A1 (en) | A soluble complex comprising a retroviral surface glycoprotein | |
WO1990015066A3 (fr) | Sequences nucleotidiques issues du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications notamment pour l'amplification des genomes de ces retrovirus et pour le diagnostic in vitro des infections dues a ces virus | |
CA2022539A1 (en) | Albumin derivatives with therapeutic functions | |
TR200001553T2 (tr) | HIV-1 Tat veya bunun türevleri. | |
WO2001010456A3 (en) | Peptides that block viral infectivity and methods of use thereof | |
ATE264914T1 (de) | Antivirale proteine, dafür kodierende dna, und deren verwendung | |
EA200200724A1 (ru) | Вакцина для профилактической или терапевтической иммунизации против вируса иммунодефицита человека (вич) | |
CY1112632T1 (el) | Αναστολεις ασπαρτυλ πρωτεασης | |
JP2002508338A5 (ru) | ||
MXPA02007478A (es) | Vacuna contra el virus de inmunodeficiencia humana. | |
EP0225066A3 (en) | Antigen determinant peptides and a process for the preparation thereof | |
WO2000061067A3 (fr) | Vaccin anti-vih-1 comprenant tout ou partie de la proteine tat de vih-1 | |
CA2195125A1 (en) | Difluorostatone antiviral agents | |
WO1996001110A3 (en) | Anti-hiv triple combination | |
JP2002523426A5 (ru) | ||
WO2000018433A3 (en) | Use of antigenic complexes of hiv envelope and hla class i antigens as hiv vaccine | |
WO2004041194A3 (en) | Inhibition of hiv-1 replication | |
FR2647809B1 (fr) | Amorces oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications au diagnostic in vitro des infections dues a ces virus | |
JP2007515386A5 (ru) | ||
RU2003125554A (ru) | Природные антитела, активные против вируса иммунодефицита человека (вич) | |
FR2652091B1 (fr) | Sequences nucleotidiques issues du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications notamment pour l'amplification des genomes de ces retrovirus et pour le diagnostic in-vitro des infections dues a ces virus. | |
WO1999061011A3 (de) | Verwendung eines arzneimittels mit einem gehalt an tyrothricin zur behandlung von virusinfektionen | |
DK0685235T3 (da) | Ekstrakter af Piliostigma thonningii, anvendelse heraf og formuleringer, som indeholder dem | |
NO963254D0 (no) | Makrocykliske difluorstatonderivater som er anvendbare som antivirale midler | |
RU2003116404A (ru) | Штамм вируса западного энцефаломиелита лошадей (western encephalomyelitis virus-wee 163-a) гкв n 964 для приготовления диагностических и профилактических препаратов |